新型转移抑制剂PI3KC2β在乳腺癌中通过mTORC1信号进行介导
Kanakaraju Manupati1, Mingang Hao2, Suhua Li1
1University of Cincinnati College of Medicine, Cincinnati, OH, United States.
Molecular cancer research : MCR
|May 13, 2025
概括
二等级的酸丁醇3-酶 (PI3KC2β) 抑制了HER2阳性乳腺癌的转移. 较低的PI3KC2β水平与较差的存活率相关,并且向mTORC1途径可能提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 在25%的乳腺癌中,HER2放大驱动转移,因此需要识别新的转移媒介基因.
- 了解HER2阳性乳腺癌的转移对于开发向疗法至关重要.
研究的目的:
- 确定调节HER2阳性乳腺癌转移的新型基因.
- 描述二类酸丁醇3-激酶 (PI3KC2β) 在HER2阳性乳腺癌转移中的作用.
主要方法:
- 在活体CRISPR-Cas9查与自相关的基因在小鼠HER2阳性乳腺癌细胞 (N418) 中.
- 在体外迁移和入侵试验,体内自发和实验转移试验.
- 对乳腺癌患者数据库和组织样本的分析;对mTORC1信号和蛋白质复合体形成的评估.
主要成果:
- 在N418细胞中的PI3KC2β删除增加了迁移,入侵和肺转移.
- 患者PI3KC2β表达的降低与转移和存活率的降低相关.
- PI3KC2β删除通过影响其与ITSN1和猛禽的复合体来激活mTORC1信号,从而增加了猛禽的稳定性.
结论:
- 在HER2阳性乳腺癌中,PI3KC2β通过负调节mTORC1信号来作为转移抑制剂.
- PI3KC2β可以作为HER2阳性乳腺癌转移的诊断标记物和治疗点.
- 在PI3KC2β缺陷模型中,mTORC1通路的抑制,例如,用拉巴胺,减少了转移.
更多相关视频
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
7.0K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.5K
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
01:20The JAK-STAT Signaling Pathway
8.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.4K